PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2023 | $31,742 | +23.0% | 33,168 | +77.3% | 0.00% | – |
| Q4 2022 | $25,814 | -26.2% | 18,706 | -33.7% | 0.00% | – |
| Q3 2022 | $35,000 | -62.0% | 28,218 | -27.7% | 0.00% | – |
| Q2 2022 | $92,000 | -43.6% | 39,023 | -25.5% | 0.00% | – |
| Q1 2022 | $163,000 | -71.8% | 52,348 | -42.6% | 0.00% | – |
| Q4 2021 | $579,000 | +70.3% | 91,188 | +167.5% | 0.00% | – |
| Q3 2021 | $340,000 | -29.6% | 34,093 | -6.7% | 0.00% | – |
| Q2 2021 | $483,000 | -5.7% | 36,529 | +24.8% | 0.00% | – |
| Q1 2021 | $512,000 | +84.8% | 29,280 | +170.4% | 0.00% | – |
| Q4 2020 | $277,000 | +489.4% | 10,829 | +203.6% | 0.00% | – |
| Q3 2020 | $47,000 | -71.2% | 3,567 | -40.2% | 0.00% | – |
| Q2 2020 | $163,000 | +30.4% | 5,963 | -24.9% | 0.00% | – |
| Q1 2020 | $125,000 | – | 7,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |